Follow the Thyrocare Tech stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Tech has recorded 7 public disclosures. Market capitalisation: €95.7bn. The latest transaction was reported on 1 July 2026 (Acquisition). Among the most active insiders: Nikhil Bodhankar. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€3,443
2 ops.
Buy Volume
€8,006
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Thyrocare Tech Strong Buy (bullish), based on 5 analysts. Average price target: ₹649.00.
45Σ signal
Buys €3,443€8,006 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,742 of 28,717 companies
61.3
score / 100
Value
34
Quality
88
FCF yld2.1%
Earn yld1.8%
EV/EBITDA33.8x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
450 shares@ ₹546.50100.0% of flowEquity SharesMarket PurchaseSEBI:0bc61903aea47be541ecd5b3d45888e8252e5dff
Canonical exit: 10 Sept 2026 (T+90)
7 of 7 declarations
About Thyrocare Tech
Thyrocare Tech is a company specializing in diagnostic and laboratory testing services. It primarily operates in the Indian market and is listed on the Bombay Stock Exchange.